SCHEMBL6000503

SCHEMBL6000503

CC(C)(C)c1ccc(C2CCC(CCNc3ccc(-c4csc(CN(CC(=O)O)Cc5ccccc5)n4)cc3)CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 2/20 0.40
GIPR P48546 2/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
DGAT1 O75907 6/20 0.38
NAMPT P43490 1/20 0.37
ADRB3 P13945 1/20 0.37
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
POLB P06746 1/20 0.35
MMP1 P03956 3/20 0.35
MMP13 P45452 3/20 0.35
MMP2 P08253 2/20 0.35
MMP9 P14780 2/20 0.35
CPB1 P15086 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000199 0.91 NAMPT (0.38) GCGRGIPRPTPN2PTPN1DGAT1
SCHEMBL6000498 0.86 GCGR (0.41) GCGRGIPRPTPN2PTPN1DGAT1
SCHEMBL6000499 0.86 GCGR (0.41) GCGRGIPRPTPN2PTPN1DGAT1
SCHEMBL6000797 0.83 MEN1 (0.43) PTPN2PTPN1DGAT1NAMPTADRB3
SCHEMBL6000792 0.83 MEN1 (0.43) PTPN2PTPN1DGAT1NAMPTADRB3
SCHEMBL6000607 0.83 MEN1 (0.44) GCGRPTPN2PTPN1NAMPTADRB3
SCHEMBL5999761 0.82 MEN1 (0.43) PTPN2PTPN1NAMPTADRB3MEN1
SCHEMBL6001063 0.79 MEN1 (0.48) GCGRGIPRPTPN2PTPN1NAMPT
SCHEMBL6000984 0.77 MEN1 (0.42) GCGRGIPRPTPN2PTPN1NAMPT
SCHEMBL5999152 0.77 MEN1 (0.43) GCGRGIPRNAMPTADRB3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 GCGR 194/4885GIPR 138/4885PTPN2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.